Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study’s Sample—Ethical Considerations
2.2. PF Questionnaires and Statistical Analysis
- The Australian PF Questionnaire (APFQ)
- The PF Distress Inventory/PF Disability Index (PFDI-20)
- The PF Impact Questionnaire-7 (PFIQ-7) for the three different systems (urinary, gastrointestinal, and reproductive).
- The personal data form was developed following an in-depth literature review and was evaluated for content validity by two experienced gynecologists.
2.3. Reliability of Scales
2.4. Study’s Limitations
3. Results
3.1. Obstetric History
3.2. Age and UP
3.3. Number of Births and UP
- Between one and no births: 6.3/5.3 = 1.19
- Between two and one birth: 14.1/6.3 = 2.24
- Between three or more and two births: 32.1/14.1 = 2.28
3.4. Delivery Mode and UP
3.5. Menopause and UP
3.6. Model for Predicting the Probability of UP
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Public Involvement Statement
Guidelines and Standards Statement
Use of Artificial Intelligence
Conflicts of Interest
References
- Badacho, A.S.; Lelu, M.A.; Gelan, Z.; Woltamo, D.D. Uterine prolapse and associated factors among reproductive-age women in south-west Ethiopia: A community-based cross-sectional study. PLoS ONE 2022, 17, e0262077. [Google Scholar] [CrossRef] [PubMed]
- Hemming, C.; Constable, L.; Goulao, B.; Kilonzo, M.; Boyers, D.; Elders, A.; Cooper, K.; Smith, A.; Freeman, R.; Breeman, S.; et al. Surgical interventions for uterine prolapse and for vault prolapse: The two VUE RCTs. Health Technol. Assess. 2020, 24, 1–220. [Google Scholar] [CrossRef]
- American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin. Pelvic Organ Prolapse. Am. Coll. Obstet. Gynecol. 2017, 30, e234. Available online: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/11/pelvic-organ-prolapse (accessed on 1 February 2025).
- Espiño-Albela, A.; Castaño-García, C.; Díaz-Mohedo, E.; Ibáñez-Vera, A.J. Effects of pelvic-floor muscle training in patients with pelvic organ prolapse approached with surgery vs. conservative treatment: A systematic review. J. Pers. Med. 2022, 12, 806. [Google Scholar] [CrossRef] [PubMed]
- Rountis, A.; Zacharakis, D.; Athanasiou, S.; Kathopoulis, N.; Grigoriadis, T.; Rountis, A.N. The role of laparoscopic surgery in the treatment of advanced uterine prolapse: A systematic review of the literature. Cureus 2021, 13, e18281. [Google Scholar] [CrossRef]
- Fontenele, M.Q.S.; Moreira, M.A.; de Moura, A.C.R.; de Figueiredo, V.B.; Driusso, P.; Nascimento, S.L. Pelvic floor dysfunction distress is correlated with quality of life, but not with muscle function. Arch. Gynecol. Obstet. 2021, 303, 143–149. [Google Scholar] [CrossRef]
- Shek, K.L.; Dietz, H.P. Assessment of pelvic organ prolapse: A review. Ultrasound Obstet. Gynecol. 2016, 48, 681–692. [Google Scholar] [CrossRef]
- Enklaar, R.A.; Knapen, F.M.; Schulten, S.F.; van Osch, L.A.; van Leijsen, S.A.; Gondrie, E.T.; Weemhoff, M. The modified Manchester Fothergill procedure compared with vaginal hysterectomy with low uterosacral ligament suspension in patients with pelvic organ prolapse: Long-term outcome. Int. Urogynecol. J. 2023, 34, 155–164. [Google Scholar] [CrossRef]
- Scime, N.V.; Ramage, K.; Brennand, E.A. Protocol for a prospective multisite cohort study investigating hysterectomy versus uterine preservation for pelvic organ prolapse surgery: The HUPPS study. BMJ Open 2021, 11, e053679. [Google Scholar] [CrossRef]
- Brunes, M.; Johannesson, U.; Drca, A.; Bergman, I.; Söderberg, M.; Warnqvist, A.; Ek, M. Recurrent surgery in uterine prolapse: A nationwide register study. Acta Obstet. Gynecol. Scandinavica 2022, 101, 532–541. [Google Scholar] [CrossRef]
- Shi, W.; Guo, L. Risk factors for the recurrence of pelvic organ prolapse: A meta-analysis. J. Obstet. Gynaecol. 2023, 43, 2160929. [Google Scholar] [CrossRef] [PubMed]
- Aboseif, C.; Liu, P. Pelvic Organ Prolapse. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2024. [Google Scholar]
- Obsa, M.S.; Worji, T.; Kedir, N.; Kute, N. Risk factors of pelvic organ prolapse at Asella Teaching and Referral Hospital: Unmatched case control study. Front. Glob. Womens Health 2022, 3, 833823. [Google Scholar] [CrossRef] [PubMed]
- Schulten, S.F.; Claas-Quax, M.J.; Weemhoff, M.; van Eijndhoven, H.W.; van Leijsen, S.A.; Vergeldt, T.F.; IntHout, J.; Kluivers, K.B. Risk factors for primary pelvic organ prolapse and prolapse recurrence: An updated systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2022, 227, 192–208. [Google Scholar] [CrossRef]
- Maher, C.; Feiner, B.; Baessler, K.; Christmann-Schmid, C.; Haya, N.; Brown, J. Surgery for women with anterior compartment prolapse. Cochrane Database Syst. Rev. 2016, 11, CD004014. [Google Scholar] [CrossRef]
- Wu, Y.M.; Welk, B. Revisiting current treatment options for stress urinary incontinence and pelvic organ prolapse: A contemporary literature review. Res. Rep. Urol. 2019, 11, 179–188. [Google Scholar] [CrossRef] [PubMed]
- Billis, E.; Kritikou, S.; Konstantinidou, E.; Fousekis, K.; Deltsidou, A.; Sergaki, C.; Giannitsas, K. The Greek version of the Australian Pelvic Floor Questionnaire: Cross-cultural adaptation and validation amongst women with urinary incontinence. Eur. J. Obstet. Gynecol. Reprod. Biol. 2022, 279, 171–175. [Google Scholar] [CrossRef] [PubMed]
- Lin, K.Y.; Frawley, H.; Granger, C. Denehy L. The Australian Pelvic Floor Questionnaire is a valid measure of pelvic floor symptoms in patients following surgery for colorectal cancer. Neurourol. Urodyn. 2017, 36, 1395–1402. [Google Scholar] [CrossRef]
- Gleason, J.L.; Parden, A.M.; Jauk, V.; Ballard, A.; Sung, V.; Richter, H.E. Outcomes of midurethral sling procedures in women with mixed urinary incontinence. Int. Urogynecology J. 2015, 26, 715–720. [Google Scholar] [CrossRef]
- Sanchez-Sanchez, B.; Torres-Lacomba, M.; Yuste-Sánchez, M.J.; Navarro-Brazalez, B.; Pacheco-da-Costa, S.; Gutierrez-Ortega, C.; Zapico-Goni, A. Cultural adaptation and validation of the Pelvic Floor Distress Inventory short form (PFDI-20) and Pelvic Floor Impact Questionnaire short form (PFIQ-7) Spanish versions. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 170, 281–285. [Google Scholar] [CrossRef]
- Bochenska, K.; Grzybowska, M.E.; Piaskowska-Cala, J.; Mueller, M.; Lewicky-Gaupp, C.; Wydra, D.; Kenton, K. Translation and validation of the polish version of the pelvic floor impact questionnaire short form 7. Int. Urogynecol. J. 2021, 32, 3177–3181. [Google Scholar] [CrossRef]
- Parvathavarthini, K.V.; Vanusha, A. Clinical epidemiological study of uterine prolapse. Int. J. Reprod. Contracept. Obstet. Gynecol. 2018, 8, 79. [Google Scholar] [CrossRef]
- Joseph, N.; Krishnan, C.; Reddy, B.A.; Adnan, N.A.; Han, L.M.; Min, Y.J. Clinical profile of uterine prolapse cases in South India. J. Obstet. Gynaecol. India 2016, 66 (Suppl. S1), 428–434. [Google Scholar] [CrossRef] [PubMed]
- Gumanga, S.K.; Munkaila, A.; Malechi, H. Social demographic characteristics of women with pelvic organ prolapse at the Tamale Teaching Hospital, Ghana. Ghana Med. J. 2014, 48, 208–213. [Google Scholar] [CrossRef]
- Yuk, J.S.; Lee, J.H.; Hur, J.Y.; Shin, J.H. The prevalence and treatment pattern of clinically diagnosed pelvic organ prolapse: A Korean National Health Insurance Database-based cross-sectional study 2009–2015. Sci. Rep. 2018, 8, 1334. [Google Scholar] [CrossRef]
- Al-Badr, A.; Saleem, Z.; Kaddour, O.; Almosaieed, B.; Dawood, A.; Al-Tannir, M.; AlTurki, F.; Alharbi, R.; Alsanea, N. Prevalence of pelvic floor dysfunction: A Saudi national survey. BMC Womens Health 2022, 22, 27. [Google Scholar] [CrossRef]
- Malaekah, H.; Al Medbel, H.S.; Al Mowallad, S.; Al Asiri, Z.; Albadrani, A.; Abdullah, H. Prevalence of pelvic floor dysfunction in women in Riyadh, Kingdom of Saudi Arabia: A cross-sectional study. Womens Health 2022, 18, 17455065211072252. [Google Scholar] [CrossRef]
- Mekonnen, B.D. Prevalence and factors associated with uterine prolapse among gynecologic patients at university of Gondar comprehensive specialized hospital, northwest Ethiopia. J. Womens Health Care 2020, 9, 492. [Google Scholar]
- Lin, Y.L.; Lo, T.S.; Long, C.Y.; Law, K.S.; Ho, C.H.; Wu, M.P. Time-frame comparison of hystero-preservation in the surgical treatment of uterine prolapse: A population-based nation-wide follow-up descriptive study, 2006–2013 versus 1997–2005. Int. Urogynecol. J. 2020, 31, 1839–1850. [Google Scholar] [CrossRef]
- Weintraub, A.Y.; Glinter, H.; Marcus-Braun, N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int. Braz J. Urol. 2020, 46, 5–14. [Google Scholar] [CrossRef]
- Kayembe, A.T.; Kayembe, C.D.K.; Bebele, J.P.K.; Tozin, R.R. Factors associated with genital prolapse to Saint Joseph Hospital of Kinshasa. Pan. Afr. Med. J. 2021, 40, 234. [Google Scholar] [CrossRef]
- Wu, J.M.; Vaughan, C.P.; Goode, P.S.; Redden, D.T.; Burgio, K.L.; Richter, H.E.; Markland, A.D. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet. Gynecol. 2014, 123, 141–148. [Google Scholar] [CrossRef] [PubMed]
- Zeleke, B.; Bell, R.; Billah, B.; Davis, S. Symptomatic pelvic floor disorders in community-dwelling older Australian women. Maturitas 2016, 85, 34–41. [Google Scholar] [CrossRef] [PubMed]
- Tegerstedt, G.; Maehle-Schmidt, M.; Nyrén, O.; Hammarström, M. Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int. Urogynecol. J. Pelvic. Floor Dysfunct. 2005, 16, 497–503. [Google Scholar] [CrossRef]
- Islam, R.M.; Bell, R.J.; Billah, B.; Hossain, M.B.; Davis, S.R. The prevalence of symptomatic pelvic floor disorders in women in Bangladesh. Climacteric 2016, 19, 558–564. [Google Scholar] [CrossRef]
- Tugume, R.; Lugobe, H.M.; Kato, P.K.; Kajabwangu, R.; Kanyesigye, H.; Masembe, S.; Kayondo, M. Pelvic organ prolapse and its associated factors among women attending the gynecology outpatient clinic at a tertiary hospital in southwestern Uganda. Int. J. Womens Health 2022, 14, 625–633. [Google Scholar] [CrossRef]
- Handa, V.L.; Blomquist, J.L.; Knoepp, L.R.; Hoskey, K.A.; McDermott, K.C.; Muñoz, A. Pelvic floor disorders 5–10 years after vaginal or cesarean childbirth. Obstet. Gynecol. 2011, 118, 777–784. [Google Scholar] [CrossRef]
- Awotunde, O.T.; Fehintola, A.O.; Ogunlaja, O.A.; Olujide, L.O.; Aaron, O.I.; Bakare, B.; Ogunlaja, I.P. An audit of uterovaginal prolapse in Ogbomoso, south-west Nigeria. Res. J. Health Sci. 2016, 4, 31–36. [Google Scholar]
- Saimin, J.; Hafizah, I.; Indriyani, N.; Wicaksono, S. Uterine prolapse in postmenopausal women in the coastal areas. Indones. J. Obstet. Gynecol. 2020, 8, 203–206. [Google Scholar] [CrossRef]
- Metz, M.; Junginger, B.; Henrich, W.; Baeßler, K. Development and validation of a questionnaire for the assessment of pelvic floor disorders and their risk factors during pregnancy and postpartum Geburtshilfe Frauenheilkd. Geburtshilfe Frauenheilkd. 2017, 77, 358–365. [Google Scholar] [CrossRef]
- Shrestha, B.; Onta, S.; Choulagai, B.; Paudel, R.; Petzold, M.; Krettek, A. Uterine prolapse and its impact on quality of life in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Bhaktapur, Nepal. Glob. Health Action 2015, 8, 28771. [Google Scholar] [CrossRef]
- Baessler, K.; O’Neill, S.; Maher, C.; Battistutta, D. Australian pelvic floor questionnaire: A validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int. Urogynecol. J. Pelvic. Floor Dysfunct. 2009, 20, 149–158. [Google Scholar] [CrossRef] [PubMed]
Variable | Mean | Median | Standard Deviation (s) | Minimum | Maximum |
---|---|---|---|---|---|
Age (years) | 51.51 | 52 | 13.181 | 21 | 82 |
Height (cm) | 163.39 | 163.5 | 6.421 | 149 | 183 |
Weight (kg) | 70.694 | 69 | 12.223 | 48 | 109 |
Body Mass Index (BMI) | 26.5132 | 25.6203 | 4.5133 | 18.29 | 40.86 |
Years Since Last Menstrual Period | 11.2147 | 10 | 8.2454 | 0.6 | 39 |
Duration of Problem (months) | 83.22 | 60 | 92.865 | 1 | 420 |
POP_Q_nomimal | Total | |||||
---|---|---|---|---|---|---|
0.00 | 1.00 | |||||
Number of deliveries | 0.00 | Count | 18 | 1 | 19 | |
% within births2 | 94.7% | 5.3% | 100.0% | |||
% within POP_Q_nomimal | 15.9% | 4.8% | 14.2% | |||
% of Total | 13.4% | 0.7% | 14.2% | |||
1.00 | Count | 15 | 1 | 16 | ||
% within births2 | 93.8% | 6.3% | 100.0% | |||
% within POP_Q_nomimal | 13.3% | 4.8% | 11.9% | |||
% of Total | 11.2% | 0.7% | 11.9% | |||
2.00 | Count | 61 | 10 | 71 | ||
% within births2 | 85.9% | 14.1% | 100.0% | |||
% within POP_Q_nomimal | 54.0% | 47.6% | 53.0% | |||
% of Total | 45.5% | 7.5% | 53.0% | |||
3.00 | Count | 19 | 9 | 28 | ||
% within births2 | 67.9% | 32.1% | 100.0% | |||
% within POP_Q_nomimal | 16.8% | 42.9% | 20.9% | |||
% of Total | 14.2% | 6.7% | 20.9% | |||
Total | Count | 113 | 21 | 134 | ||
% within births2 | 84.3% | 15.7% | 100.0% | |||
% within POP_Q_nomimal | 100.0% | 100.0% | 100.0% | |||
% of Total | 84.3% | 15.7% | 100.0% | |||
Mode of delivery | 0.00 | Count | 59 | 17 | 76 | |
% within birth type | 77.6% | 22.4% | 100.0% | |||
% within POP_Q_nomimal | 52.2% | 81.0% | 56.7% | |||
% of Total | 44.0% | 12.7% | 56.7% | |||
1.00 | Count | 54 | 4 | 58 | ||
% within birth type | 93.1% | 6.9% | 100.0% | |||
% within POP_Q_nomimal | 47.8% | 19.0% | 43.3% | |||
% of Total | 40.3% | 3.0% | 43.3% | |||
Total | Count | 113 | 21 | 134 | ||
% within birth type | 84.3% | 15.7% | 100.0% | |||
% within POP_Q_nomimal | 100.0% | 100.0% | 100.0% | |||
% of Total | 84.3% | 15.7% | 100.0% |
B | S.E. | Wald | df | Sig. | Exp(B) | ||
---|---|---|---|---|---|---|---|
Step 2 a | PFQ-Bladder subscore (1–15) | 0.902 | 0.271 | 11.086 | 1 | 0.001 | 2.465 |
PFQ-POP subscore (28–32) | 0.674 | 0.303 | 4.957 | 1 | 0.026 | 1.962 | |
PFQ-Sexual function subscore (33–42) | −0.473 | 0.252 | 3.525 | 1 | 0.060 | 0.623 | |
Constant | −2.434 | 0.474 | 26.327 | 1 | 0.000 | 0.088 |
Classification Table a | |||||
---|---|---|---|---|---|
Observed | Predicted | ||||
POP_Q_nomimal | Percentage Correct | ||||
0.00 | 1.00 | ||||
Step 1 | POP_Q_nomimal | 0.00 | 99 | 2 | 98.0 |
1.00 | 12 | 7 | 36.8 | ||
Overall Percentage | 88.3 | ||||
Step 2 | POP_Q_nomimal | 0.00 | 100 | 1 | 99.0 |
1.00 | 13 | 6 | 31.6 | ||
Overall Percentage | 88.3 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Loukopoulou, A.; Tzanni, E.; Bothou, A.; Billis, E.; Nanou, C.; Kyrkou, G.; Vivilaki, V.; Deltsidou, A. Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece. Nurs. Rep. 2025, 15, 212. https://doi.org/10.3390/nursrep15060212
Loukopoulou A, Tzanni E, Bothou A, Billis E, Nanou C, Kyrkou G, Vivilaki V, Deltsidou A. Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece. Nursing Reports. 2025; 15(6):212. https://doi.org/10.3390/nursrep15060212
Chicago/Turabian StyleLoukopoulou, Athina, Eleni Tzanni, Anastasia Bothou, Evdokia Billis, Christina Nanou, Giannoula Kyrkou, Victoria Vivilaki, and Anna Deltsidou. 2025. "Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece" Nursing Reports 15, no. 6: 212. https://doi.org/10.3390/nursrep15060212
APA StyleLoukopoulou, A., Tzanni, E., Bothou, A., Billis, E., Nanou, C., Kyrkou, G., Vivilaki, V., & Deltsidou, A. (2025). Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece. Nursing Reports, 15(6), 212. https://doi.org/10.3390/nursrep15060212